Scientific Sessions: Emerging and Re-emerging Infectious Diseases,   Antimicrobial Resistance and Stewardship, Vaccine Development and Immunization Programs,Diagnostic Innovations in Infectious Diseases, COVID-19 and Lessons for Future Pandemics, Viral Hepatitis: HBV, HCV, and New Therapies, HIV/AIDS Research, Prevention, and Treatment, Vector-Borne Diseases: Malaria, Dengue, Zika, Tuberculosis: New Strategies in Control and Elimination, Pediatric Infectious Diseases, Geriatric Infections and Complications, Hospital-Acquired and Healthcare-Associated Infections, Fungal Infections and Invasive Mycoses, Bacterial Pathogenesis and Host Response, Infections in Immunocompromised Patients, Zoonotic Infections and Cross-Species Transmission, Sexually Transmitted Infections (STIs), Global Surveillance and Epidemiological Modeling, One Health: Human-Animal-Environment,Interface Infectious Disease in Travel and Migration, Climate Change and Emerging Infectious Threats, Microbiome Disruption and Infectious Outcomes, Precision Medicine and Infectious Diseases, Antiviral and Antibacterial Drug Discovery, Infection Control and Public Health Policy, Biothreats, Bioterrorism, and Emerging Pathogens, Role of AI in Infectious Disease Management, Case Studies in Infectious Disease Research and Clinical Practice, Others